Canada Life
MRTX

Canada Life’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Canada Life’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,241
Closed -$948K – 2168
2023
Q4 		$948K Buy
16,241
+11,436
+238% +$643K ﹤0.01% 1520
2023
Q3 		$209K Buy
4,805
+1,860
+63% +$66.4K ﹤0.01% 1849
2023
Q2 		$107K Buy
2,945
+701
+31% +$28.9K ﹤0.01% 1920
2023
Q1 		$84K Buy
2,244
+121
+6% +$5.44K ﹤0.01% 1999
2022
Q4 		$97K Buy
2,123
+49
+2% +$3.17K ﹤0.01% 1990
2022
Q3 		$145K Buy
2,074
+32
+2% +$2.37K ﹤0.01% 1925
2022
Q2 		$137K Buy
2,042
+30
+1% +$1.91K ﹤0.01% 1875
2022
Q1 		$176K Sell
2,012
-53
-3% -$5.42K ﹤0.01% 1898
2021
Q4 		$302K Buy
2,065
+30
+1% +$4.66K ﹤0.01% 1803
2021
Q3 		$362K Hold
2,035
– – ﹤0.01% 1787
2021
Q2 		$329K Sell
2,035
-187
-8% -$30K ﹤0.01% 1827
2021
Q1 		$378K Buy
2,222
+105
+5% +$20.8K ﹤0.01% 1802
2020
Q4 		$464K Hold
2,117
– – ﹤0.01% 1766
2020
Q3 		$351K Hold
2,117
– – ﹤0.01% 1772
2020
Q2 		$240K Buy
2,117
+354
+20% +$34.3K ﹤0.01% 1871
2020
Q1 		$137K Hold
1,763
– – ﹤0.01% 1910
2019
Q4 		$226K Buy
+1,763
New +$170K ﹤0.01% 1901
2019
Q3 		– Sell
-3,130
Closed -$322K – 2425
2019
Q2 		$322K Hold
3,130
– – ﹤0.01% 1910
2019
Q1 		$229K Buy
3,130
+1,149
+58% +$78.2K ﹤0.01% 1843
2018
Q4 		$81K Hold
1,981
– – ﹤0.01% 2218
2018
Q3 		$93K Hold
1,981
– – ﹤0.01% 2216
2018
Q2 		$97K Buy
+1,981
New +$74.8K ﹤0.01% 2192

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Canada Life's MRTX Position: Q1 2024 in Review

Canada Life sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 16,241 shares — an estimated $948K sold.

Canada Life first reported a position in MRTX in Q2 2018 and held it in 22 quarters. The position peaked at $948K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Canada Life reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Canada Life sold 16,241 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $948K.
  • Canada Life first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2018 and held it in 22 quarters.
  • Canada Life's Mirati Therapeutics, Inc. Common Stock position peaked at $948K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Canada Life's 13F filing for Q1 2024, filed 13 May 2024.